- Filed
- Dec 17, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2022 · Dec 16, 2021 | 199.63M sh |
| Cash And Equivalents | Q2 2022 · Oct 31, 2021 | $698.64K |
| Cash And Equivalents | Q2 2022 · Apr 30, 2021 | $1.57M |
| Cash And Equivalents | Q2 2022 · Oct 31, 2020 | $396.58K |
| Cash And Equivalents | Q2 2022 · Apr 30, 2020 | $1.14M |
| Stockholders Equity | Q2 2022 · Oct 31, 2021 | $8.19M |
| Stockholders Equity | Q2 2022 · Apr 30, 2021 | $9.77M |
| Current Liabilities | Q2 2022 · Oct 31, 2021 | $26.5M |
| Current Liabilities | Q2 2022 · Apr 30, 2021 | $23.94M |
| Total Liabilities | Q2 2022 · Oct 31, 2021 | $26.5M |
| Total Liabilities | Q2 2022 · Apr 30, 2021 | $23.94M |
| Current Assets | Q2 2022 · Oct 31, 2021 | $21.63M |
| Current Assets | Q2 2022 · Apr 30, 2021 | $22.85M |
| Total Assets | Q2 2022 · Oct 31, 2021 | $32.06M |
| Total Assets | Q2 2022 · Apr 30, 2021 | $32.07M |
| Shares Diluted | Q2 2022 · Oct 31, 2020 | 199.63M sh |
| Shares Diluted | Q2 2022 · Oct 31, 2020 | 199.63M sh |
| Capex | Q2 2022 · Oct 31, 2020 | $97.29K |
| Sga Expense | Q2 2022 · Oct 31, 2020 | $172.38K |
| Sga Expense | Q2 2022 · Oct 31, 2020 | $645.56K |
| Rd Expense | Q2 2022 · Oct 31, 2020 | $71.13K |
| Rd Expense | Q2 2022 · Oct 31, 2020 | $432.57K |
| Net Income restated | Q2 2022 · Oct 31, 2020 | −$403.38K |
| Net Income restated | Q2 2022 · Oct 31, 2020 | −$1.07M |
| Operating Income | Q2 2022 · Oct 31, 2020 | −$604.19K |
| Operating Income | Q2 2022 · Oct 31, 2020 | −$1.58M |
| Gross Profit | Q2 2022 · Oct 31, 2020 | −$104.11K |
| Gross Profit | Q2 2022 · Oct 31, 2020 | $63.07K |
| Revenue | Q2 2022 · Oct 31, 2020 | $4.43M |
| Revenue | Q2 2022 · Oct 31, 2020 | $11.47M |